When Congress asked that anthrax vaccine shots for soldiers be discontinued until more research is done, the Pentagon said no. Soldiers can still be court-martialed for refusing the vaccine. The following articles are reprinted from 1998 and 1999.
ANTHRAX & OTHER SMALL FAVORS
by Hank Roth
Admiral William J. Crowe, Jr., former chairman of the Joint Chiefs of Staff, is making a lot of money selling anthrax vaccine.
If it smells fishy, it isn't because the Admiral spent so much time at sea. He mostly steered his career from desk to desk, as an aide to admirals, a White House assistant, staff officer, Ambassador, graduate student, Pentagon planner, and top dog at JCS.
Intervac L.L.C., of which Retired Adm. William J. Crowe, Jr. is director--a pharmaceutical investment firm in Maryland--under the newly formed BioPort Inc., bid $25 million to buy the Michigan Biologic Products Institute. The offer included $3.25 million in cash at closing, $12.1 million in secured notes, $4.